Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02436005 · ClinicalTrials.gov registry record · NA

Dispensing Study for the Phenacite Project

A NA study, sponsored by CooperVision.

Completed
Registry status
NA
Development phase
25
Enrollment target

NCT02436005: Completed NA study, sponsored by CooperVision.

NCT02436005 is a NA study that has completed, run by CooperVision. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02436005, a NA study, has completed, sponsored by CooperVision.

COMPLETED
Registry status
NA
Development phase
25 participants
Enrollment target

Study Summary

Dispensing Study for the Phenacite Project. The investigational test lens was not the final optical design and the study was not used for design validation.

Primary Outcome

Subjective ratings of lens comfort. Comfort Scale (0,100; 0=extremely uncomfortable/cannot tolerate; 100 = extremely comfortable/cannot be felt)

Interventions

  • DEVICE comfilcon A
  • DEVICE Phenacite

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2015-04
Est. Completion 2015-07
Phase NA
CooperVision

64 total trials

What the finished NCT02436005 record still lists

NCT02436005 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which comfilcon A is the first listed.

NCT02436005 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02436005 about?

NCT02436005 is a clinical study titled "Dispensing Study for the Phenacite Project". Dispensing Study for the Phenacite Project. The investigational test lens was not the final optical design and the study was not used for design validation.

What is the current status of trial NCT02436005?

This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2015-04. Estimated completion is 2015-07.

What interventions are being tested in trial NCT02436005?

The interventions under investigation include: comfilcon A (DEVICE), Phenacite (DEVICE).

Who is sponsoring clinical trial NCT02436005?

This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02436005's enrollment target sits among peer trials

25 1712th of 2000 higher than 265 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02436005, the US trial registry maintained by the National Library of Medicine. NCT02436005 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.